Orbital metastasis as a rare form of clinical presentation of non-small cell lung cancer

J Thorac Oncol. 2007 Feb;2(2):166-7. doi: 10.1097/JTO.0b013e31802c0036.

Abstract

Approximately 11 million new cases of cancer are diagnosed worldwide each year; one in eight is a lung cancer. More than one million people die of lung cancer each year, and non-small cell lung cancer accounts for approximately 80% of all cases of lung cancer. The incidence of primary tumors that metastasize to the orbit is approximately 7%. In 19% of the cases, there is no history of cancer when the patient presents with ophthalmic symptoms, and in 10%, the primary site remains obscure despite intensive systemic evaluation. We report a rare form of clinical presentation of non-small cell lung cancer in which symptoms caused by orbital metastases were the first manifestations.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Carboplatin / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Fatal Outcome
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology*
  • Magnetic Resonance Imaging
  • Male
  • Orbital Neoplasms / diagnosis
  • Orbital Neoplasms / drug therapy
  • Orbital Neoplasms / secondary*

Substances

  • Antineoplastic Agents
  • Carboplatin